title: Death-associated protein 3 is overexpressed in human thyroid oncocytic tumours.
abstract: BACKGROUND
  The human death-associated protein 3 (hDAP3) is a GTP-binding constituent of the small subunit of the mitochondrial ribosome with a pro-apoptotic function.
  
  
  METHODS
  A search through publicly available microarray data sets showed 337 genes potentially coregulated with the DAP3 gene. The promoter sequences of these 337 genes and 70 out of 85 mitochondrial ribosome genes were analysed in silico with the DAP3 gene promoter sequence. The mitochondrial role of DAP3 was also investigated in the thyroid tumours presenting various mitochondrial contents.
  
  
  RESULTS
  The study revealed nine transcription factors presenting enriched motifs for these gene promoters, five of which are implicated in cellular growth (ELK1, ELK4, RUNX1, HOX11-CTF1, TAL1-ternary complex factor 3) and four in mitochondrial biogenesis (nuclear respiratory factor-1 (NRF-1), GABPA, PPARG-RXRA and estrogen-related receptor alpha (ESRRA)). An independent microarray data set showed the overexpression of ELK1, RUNX1 and ESRRA in the thyroid oncocytic tumours. Exploring the thyroid tumours, we found that DAP3 mRNA and protein expression is upregulated in tumours presenting a mitochondrial biogenesis compared with the normal tissue. ELK1 and ESRRA were also showed upregulated with DAP3.
  
  
  CONCLUSIONS
  ELK1 and ESRRA may be considered as potential regulators of the DAP3 gene expression. DAP3 may participate in mitochondrial maintenance and play a role in the balance between mitochondrial homoeostasis and tumourigenesis.
authors.affiliation: INSERM, U694, Centre Hospitalier Universitaire d'Angers, Laboratoire de Biochimie et Biologie Moléculaire, Angers, France. caroline.jacques@univ-angers.fr
authors.forename: C
authors.initials: C
authors.lastname: Jacques
authors.forename: J-F
authors.initials: JF
authors.lastname: Fontaine
authors.forename: B
authors.initials: B
authors.lastname: Franc
authors.forename: D
authors.initials: D
authors.lastname: Mirebeau-Prunier
authors.forename: S
authors.initials: S
authors.lastname: Triau
authors.forename: F
authors.initials: F
authors.lastname: Savagner
authors.forename: Y
authors.initials: Y
authors.lastname: Malthiery
mesh_terms: D018249:Adenoma, Oxyphilic / Q000235:genetics* / Q000378:metabolism*; D051017:Apoptosis Regulatory Proteins / Q000096:biosynthesis* / Q000235:genetics*; D053843:DNA Mismatch Repair; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008928:Mitochondria / Q000235:genetics / Q000378:metabolism; D011401:Promoter Regions, Genetic; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D016601:RNA-Binding Proteins; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012269:Ribosomal Proteins / Q000096:biosynthesis* / Q000235:genetics*; D012270:Ribosomes / Q000235:genetics; D013964:Thyroid Neoplasms / Q000235:genetics* / Q000378:metabolism*; D014157:Transcription Factors / Q000235:genetics
chemical_list: D051017:Apoptosis Regulatory Proteins; C097041:DAP3 protein, human; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D012269:Ribosomal Proteins; D014157:Transcription Factors